IGF1 and neoplasm: However, obstacles such as the very slow growth rate of pHGG PDX cells in the brain and the poor access of biologics such as the IGF-Trap to the tumor site due to the blood-brain barrier will need to be overcome to achieve a therapeutic effect in vivo.